VYEPTI

PeakmAb

eptinezumab-jjmr

Lundbeck
BLAINJECTIONINJECTABLE
Approved
Feb 2020
Lifecycle
Peak
Competitive Pressure
30/100

Mechanism of Action

Calcitonin Gene-related Peptide Antagonists

Pharmacologic Class:

Calcitonin Gene-related Peptide Antagonist

Company
L
Lundbeck
Denmark - Copenhagen
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers